# Study of EXPAREL in Patients Undergoing Breast Augmentation

> **NCT01582490** · PHASE4 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 19 (actual)

## Conditions studied

- Mammoplasty
- Postoperative Pain

## Interventions

- **DRUG:** Instillation - EXPAREL
- **DRUG:** Infiltration - EXPAREL

## Key facts

- **NCT ID:** NCT01582490
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2014-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01582490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01582490, "Study of EXPAREL in Patients Undergoing Breast Augmentation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01582490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*